1.Comparison of Immunoglobulin Levels in Serum between Breast- and Formula-fed Newborns.
Tae Eun JEONG ; Sun Hoe KOO ; Jong Woo PARK ; Sang Hyun BYUN
Korean Journal of Clinical Pathology 1999;19(6):612-616
BACKGROUND: It had been well known that breast feeding to infants has many advantages and benefits comparing to formula feeding. So, We performed this study to clarify the relationship between immunoglobulin (Ig) levels and diet during newborn period. METHODS: We measured the levels of IgG, IgA and IgM by Array 360 System (Beckman Instruments, CA, U.S.A). Subjects were 29 breast-fed and 13 formula-fed newborns. We evaluated the results and analyzed the change of concentrations of IgG, IgA and IgM according to diet, sex and postnatal period. RESULTS: The levels of IgG, IgA and IgM in breast-fed newborns at postnatal 1-day were higher than formula-fed newborns, but the levels of Ig G and Ig A in formula-fed newborns at postnatal 30-day were higher than breast-fed newborns. CONCLUSIONS: There was no clinical signficance in the difference of IgG, IgA and IgM levels according to diet, sex and postnatal period, respectively.
Breast Feeding
;
Diet
;
Humans
;
Immunoglobulin A
;
Immunoglobulin G
;
Immunoglobulin M
;
Immunoglobulins*
;
Infant
;
Infant, Newborn*
2.Clinical utility of harmonic imaging in the detection of right to left shunt through patent foramen ovale by transthoracic contrast echocardiography.
Mi Seung SHIN ; Seok Min KANG ; Kil Jin JANG ; Ki Hyun BYUN ; Jong Won HA ; Namsik CHUNG ; Ji Hoe HEO ; Byung In LEE
Korean Circulation Journal 2000;30(4):433-439
BACKGROUND: Paradoxical embolism through the patent foramen ovale (PFO) is a well-recognized mechanism for otherwise unexplained ischemic stroke. Although transthoracic contrast echocardiography (TCE) has been used frequently for noninvasive diagnosis of right to left shunt through PFO, its diagnostic accuracy appears limited, especially in patients with poor acoustic window. Since harmonic imaging (HI) can enhance the definition of contrast microbubbles, theoretical advantages of HI in the detection of right to left shunt through PFO using microbubbles can be considered. However, there are few data regarding the diagnostic efficacy of HI in the detection of right to left shunt through PFO. The purpose of this study was to compare the diagnostic value of transthoracic HI in the detection of right to left shunt through PFO in patients with stroke with that of fundamental imaging (FI). Methods: One hundred thirty-six consecutive patients with stroke (82 male, mean age:9) underwent TCE in both HI and FI and transesophageal echocardiography (TEE) during rest and Valsalva maneuver with intravenous administration of agitated saline. PFO was judged to be present if microbubbles appeared in the left atrium within 3 cardiac cycles of their appearance in the right atrium. TEE was regarded as the gold standard for assessing the diagnostic accuracy of TCE. Results: Right to left shunt through PFO was detected in 40 of 136 patients by TEE (29.4%). FI of TCE detected shunt through PFO in only 9 of 136 patients (6.6%). In contrast, HI detected shunt through PFO in 25 of 136 patients (18.4%). The overall sensitivity and specificity of FI and HI for detection of right to left shunt through PFO were 22.5%, 62.5% (p<0.05) and 100%, 100%, respectively. Valsalva maneuver during HI significantly increased the detection rate of shunt through PFO (during rest in 9 and during Valsalva maneuver in 25, p<0.05). CONCLUSION: HI with contrast microbubble injection significantly enhanced the detection of right to left shunt through PFO in patients with ischemic stroke compared with FI by transthoracic approach.
Acoustics
;
Administration, Intravenous
;
Diagnosis
;
Dihydroergotamine
;
Echocardiography*
;
Echocardiography, Transesophageal
;
Embolism, Paradoxical
;
Foramen Ovale, Patent*
;
Heart Atria
;
Humans
;
Male
;
Microbubbles
;
Sensitivity and Specificity
;
Stroke
;
Valsalva Maneuver
3.A Simple, Quantitative Method for Assessing Angiogenic Genes Using Skeletal Muscle by Electroporation-Mediated Naked DNA Delivery.
Hyun Joong KIM ; Hyung Suk JANG ; Jeong Min KIM ; Yong Sam LEE ; Kyung Ree KIM ; Jeong A KIM ; Eun Seok JEON ; Jong Hoe BYUN ; Duk Kyung KIM
Korean Circulation Journal 2003;33(4):321-332
BACKGROUND AND OBJECTIVES: For the development of an arteriogenic gene therapy in peripheral artery occlusive disease, we developed a novel angiogenesis assay, with electroporation-mediated naked DNA delivery to the skeletal muscle. MATERIALS AND METHODS: The levels of the expression CAT were compared between pJDK and pcDNA3.1, in HeLa and C2C12 cell lines, and skeletal muscle. The well known angiogenic gene, pJDK-hVEGF165, was injected, intramuscularly, into the tibialis anterior muscle of Balb/C mice, which was followed by electroporation. Two days later, the anterior tibialis muscles were divided into halves, embedded, and cultured in growth factor-reduced Matrigel. The capillary network area formed by the newly sprouting tube-like structures was calculated. For validation of this ex vivo assay, the connective tissue growth factor gene (pJDK-CTGF) was tested both by this new assay, and by the mice-hind limb ischemia model, with Laser Doppler imaging. RESULTS: The pJDK showed a significantly higher level of CAT expression than the pcDNA3.1. From the pJDK-hVEGF165 injected explants, endothelial cell migration and tube-like formation occurred on day 2, and the capillary network formation peaked on day 7. The capillary network formation in the pJDK-hVEGF165 group was markedly increased to that in the pJDK group. From the skeletal muscle assay, the pJDK-CTGF showed no angiogenic activity or attenuated VEGF-induced capillary network formation. The LDI flux ratio, on day 10 in the mice-hind limb ischemia model, for the mice treated with the pJDK-CTGF and pJDK-hVEGF165 was significantly lower than that of the mice treated with the pJDK-hVEGF165 alone. CONCLUSION: The skeletal muscle ex vivo assay, using an electroporation-mediated naked DNA delivery, is a simple, quantitative and reproducible method for assessing angiogenic genes. CTGF could be an anti-angiogenic factor due to its inhibition of VEGF.
Animals
;
Arteries
;
Capillaries
;
Cats
;
Cell Line
;
Connective Tissue Growth Factor
;
DNA*
;
Electroporation
;
Endothelial Cells
;
Extremities
;
Genetic Therapy
;
Ischemia
;
Mice
;
Muscle, Skeletal*
;
Muscles
;
Vascular Endothelial Growth Factor A
4.Improved expression by cytomegalovirus promoter/enhancer and behavior of vascular endothelial growth factor gene after myocardial injection of naked DNA.
Jin Ok JEONG ; Jong Hoe BYUN ; Eun Seok JEON ; Hyeon Cheol GWON ; Young Shin LIM ; Jang Won PARK ; Seon Ju YEO ; Young Joo LEE ; Sun Young KIM ; Duk Kyung KIM
Experimental & Molecular Medicine 2002;34(4):278-284
Direct injection of the vascular endothelial growth factor (VEGF) gene plasmid DNA into the myocardium was shown to induce development of new blood vessels to increase the circulation in the heart of patients with coronary artery diseases. However, such angiogenic gene therapy (via naked DNA) was limited by low level of gene expression. Furthermore, the temporal and spatial characteristics of VEGF gene transfer in the heart are not known. In this study, we demonstrated that a plasmid vector, containing the human cytomegalovirus immediate early (HCMV IE) promoter and enhancer, induces greater expression of gene in the rat heart monitored by gene fused to the chloramphenicol acetyl transferase (CAT) reporter, than four different viral and cellular promoters. Interestingly, expression of VEGF121 protein showed an earlier peak, a shorter duration, and a wider distribution than that of CAT only. Therefore, a plasmid vector with an HCMV IE promoter/enhancer provides clear advantages over other previously developed plasmids. Furthermore, expression profile of VEGF121 gene may provide useful information in the design of angiogenic gene therapy in the heart
Animals
;
Chloramphenicol O-Acetyltransferase/analysis/genetics
;
Comparative Study
;
Cytomegalovirus/*genetics
;
DNA, Viral/*administration & dosage/*genetics
;
Endothelial Growth Factors/analysis/*genetics
;
*Enhancer Elements (Genetics)
;
Gene Expression Regulation, Viral
;
Gene Fusion
;
*Gene Transfer Techniques
;
Genes, Viral
;
Genetic Vectors
;
Intercellular Signaling Peptides and Proteins/analysis/*genetics
;
Lymphokines/analysis/*genetics
;
Male
;
Myocardium/*metabolism
;
Plasmids/genetics
;
*Promoter Regions (Genetics)
;
Rats
;
Rats, Sprague-Dawley
;
Time Factors
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factors
5.Improved expression by cytomegalovirus promoter/enhancer and behavior of vascular endothelial growth factor gene after myocardial injection of naked DNA.
Jin Ok JEONG ; Jong Hoe BYUN ; Eun Seok JEON ; Hyeon Cheol GWON ; Young Shin LIM ; Jang Won PARK ; Seon Ju YEO ; Young Joo LEE ; Sun Young KIM ; Duk Kyung KIM
Experimental & Molecular Medicine 2002;34(4):278-284
Direct injection of the vascular endothelial growth factor (VEGF) gene plasmid DNA into the myocardium was shown to induce development of new blood vessels to increase the circulation in the heart of patients with coronary artery diseases. However, such angiogenic gene therapy (via naked DNA) was limited by low level of gene expression. Furthermore, the temporal and spatial characteristics of VEGF gene transfer in the heart are not known. In this study, we demonstrated that a plasmid vector, containing the human cytomegalovirus immediate early (HCMV IE) promoter and enhancer, induces greater expression of gene in the rat heart monitored by gene fused to the chloramphenicol acetyl transferase (CAT) reporter, than four different viral and cellular promoters. Interestingly, expression of VEGF121 protein showed an earlier peak, a shorter duration, and a wider distribution than that of CAT only. Therefore, a plasmid vector with an HCMV IE promoter/enhancer provides clear advantages over other previously developed plasmids. Furthermore, expression profile of VEGF121 gene may provide useful information in the design of angiogenic gene therapy in the heart
Animals
;
Chloramphenicol O-Acetyltransferase/analysis/genetics
;
Comparative Study
;
Cytomegalovirus/*genetics
;
DNA, Viral/*administration & dosage/*genetics
;
Endothelial Growth Factors/analysis/*genetics
;
*Enhancer Elements (Genetics)
;
Gene Expression Regulation, Viral
;
Gene Fusion
;
*Gene Transfer Techniques
;
Genes, Viral
;
Genetic Vectors
;
Intercellular Signaling Peptides and Proteins/analysis/*genetics
;
Lymphokines/analysis/*genetics
;
Male
;
Myocardium/*metabolism
;
Plasmids/genetics
;
*Promoter Regions (Genetics)
;
Rats
;
Rats, Sprague-Dawley
;
Time Factors
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factors
6.Gene Transfer into Cultured Cardiac Myocytes Mediated by Retrovirus.
Jeong Eun HUH ; Duk Kyung KIM ; Jong Hoe BYUN ; Sun Jin PARK ; Eun Suk JEON ; Yoon Hyuk CHOE ; Eun A JUNG ; Hyeon Cheol GWON ; Seung Woo PARK ; June Soo KIM ; Sang Hoon LEE ; Kyung Pyo HONG ; Jeong Euy PARK ; Francois Loic COSSET ; Jung Don SEO ; Won Ro LEE
Korean Circulation Journal 1999;29(2):182-191
BACKGROUND: Transplantation of cardiac myocytes (CMs) into the injured heart emerges as a potential alternative for the treatment of heart failure. Genetic modification of CMs could enhance and/or modify its therapeutic effects. The characteristics of retroviral gene delivery, which is most commonly used in human trial, has been minimally studied in CMs due to its low efficiency in non-dividing cells. In this study, using newly developed high-titer retrovirus, we evaluated 1) the efficiency of gene transfer into CMs, 2) whether S phase during infection is necessary for the transduction, and 3) characteristics of gene delivery to mononucleated vs binucleated CMs. METHODS: Enriched CMs were cultured from the ventricles of 1 day-old rat hearts. The cells were transduced by MFG-nls-LacZ retroviruses (5x107 IU/ml) in the presence or absence of polybrene. 3H-thymidine was added to label cells in S phase. The cells were stained for
Animals
;
Autoradiography
;
Cells, Cultured
;
Dichlorodiphenyldichloroethane
;
Genetic Therapy
;
Heart
;
Heart Failure
;
Hexadimethrine Bromide
;
Humans
;
Myocytes, Cardiac*
;
Rats
;
Retroviridae*
;
S Phase
;
Thymidine
;
Zidovudine
7.Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.
Dae Hoe GU ; Moon Young KIM ; Yeon Seok SEO ; Sang Gyune KIM ; Han Ah LEE ; Tae Hyung KIM ; Young Kul JUNG ; Altay KANDEMIR ; Ji Hoon KIM ; Hyunggin AN ; Hyung Joon YIM ; Jong Eun YEON ; Kwan Soo BYUN ; Soon Ho UM
Clinical and Molecular Hepatology 2018;24(3):319-330
BACKGROUND/AIMS: The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height (PMTH) is also effective for detecting sarcopenia and predicting prognosis in patients with cirrhosis. The aim of this study was to evaluate the optimal cutoff values of PMTH for detecting sarcopenia in cirrhotic patients. METHODS: All cirrhotic patients who underwent abdominal computed tomography (CT) scan including L3 and umbilical levels for measuring SMI and transverse psoas muscle thickness, respectively, were included. Two definitions of sarcopenia were used: (1) sex-specific cutoffs of SMI (≤52.4 cm² /m² in men and ≤38.5 cm² /m² in women) for SMI-sarcopenia and (2) cutoff of PMTH ( < 16.8 mm/m) for PMTH-sarcopenia. RESULTS: Six hundred fifty-three patients were included. The average age was 53.6 ± 10.2 years, and 499 patients (76.4%) were men. PMTH correlated well with SMI in both men and women (P < 0.001). Two hundred forty-one (36.9%) patients met the criteria for SMI-sarcopenia. The best PMTH cutoff values for predicting SMI-sarcopenia were 17.3 mm/m in men and 10.4 mm/m in women, and these were defined as sex-specific cutoffs of PMTH (SsPMTH). The previously published cutoff of PMTH was defined as sex-nonspecific cutoff of PMTH (SnPMTH). Two hundred thirty (35.2%) patients were diagnosed with SsPMTH-sarcopenia, and 280 (44.4%) patients were diagnosed with SnPMTH-sarcopenia. On a multivariate Cox regression analysis, SsPMTH-sarcopenia (hazard ratio [HR], 1.944; 95% confidence interval [CI], 1.144–3.304; P=0.014) was significantly associated with mortality, while SnPMTH-sarcopenia was not (HR, 1.446; 95% CI, 0.861–2.431; P=0.164). CONCLUSIONS: PMTH was well correlated with SMI in cirrhotic patients. SsPMTH-sarcopenia was an independent predictor of mortality in these patients and more accurately predicted mortality compared to SnPMTH-sarcopenia.
Diagnosis*
;
Female
;
Fibrosis
;
Humans
;
Liver Cirrhosis*
;
Liver*
;
Male
;
Methods
;
Mortality
;
Muscle, Skeletal
;
Prognosis
;
Psoas Muscles*
;
Sarcopenia*